Published in Eur J Surg Oncol on May 01, 2003
Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. Mol Cell Biol (2004) 1.31
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol (2010) 1.15
Epigenetics and breast cancers. Obstet Gynecol Int (2012) 0.99
Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int J Mol Sci (2010) 0.98
siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer (2009) 0.96
Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. PLoS One (2014) 0.88
Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer (2010) 0.88
hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics. Oncol Lett (2013) 0.86
Telomere and Telomerase Therapeutics in Cancer. Genes (Basel) (2016) 0.81
Inhibition of UBE2D3 expression attenuates radiosensitivity of MCF-7 human breast cancer cells by increasing hTERT expression and activity. PLoS One (2013) 0.81
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis. Int J Clin Oncol (2011) 0.80
Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner. Mol Biol Rep (2013) 0.80
The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. J Carcinog (2004) 0.77
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer. Int Semin Surg Oncol (2004) 0.77
MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells. Oncotarget (2016) 0.76
The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters. Int Semin Surg Oncol (2006) 0.75
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC. Front Cell Dev Biol (2017) 0.75
Cephalotaxus griffithii Hook.f. needle extract induces cell cycle arrest, apoptosis and suppression of hTERT and hTR expression on human breast cancer cells. BMC Complement Altern Med (2014) 0.75
Repression of telomere-associated genes by microglia activation in neuropsychiatric disease. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression. Oncotarget (2017) 0.75
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
STUDIES IN CONGESTIVE HEART FAILURE. XXIIII. A CRITICAL STUDY OF METHODS FOR DETERMINING THE CARDIAC OUTPUT IN PATIENTS WITH CARDIAC DISEASE. J Clin Invest (1933) 6.31
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
STUDIES IN CONGESTIVE HEART FAILURE: III. The Buffering Power of the Blood and Tissues. J Clin Invest (1930) 4.52
Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol (1969) 4.45
SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet (1998) 3.79
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (1983) 2.77
The Hillsborough tragedy. BMJ (1991) 2.36
HIV gp120 receptors on human dendritic cells. Blood (2001) 2.03
Meticillin-resistant Staphylococcus aureus carriage among district nurse patients and medical admissions in a UK district. J Hosp Infect (2007) 1.98
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst (1999) 1.73
Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification. Nature (1980) 1.71
Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res (2001) 1.54
Male ritual circumcision resulting in acute renal failure. BMJ (1994) 1.45
Lung bioavailability of generic and innovator salbutamol metered dose inhalers. Thorax (1996) 1.43
Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells. Nature (1976) 1.40
The importance of being K-Ras. Cell Signal (2000) 1.40
Mutation of putative branchpoint consensus sequences in plant introns reduces splicing efficiency. Plant J (1996) 1.36
Human acrocentric chromosomes with transcriptionally silent nucleolar organizer regions associate with nucleoli. EMBO J (2001) 1.35
Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics (1994) 1.31
Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol (2005) 1.26
Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature (1982) 1.26
Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction. Surg Oncol (2008) 1.23
A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22
Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenet Cell Genet (1995) 1.21
The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer (2009) 1.20
Glucose synthesis in tritiated water. Eur J Biochem (1974) 1.19
Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res (2001) 1.18
WNT5A expression in human breast cancer. Anticancer Res (2005) 1.18
Methodology for constructing guidance. J Clin Pathol (2005) 1.15
In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients. Ann Oncol (1998) 1.14
The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones. Am J Otol (2000) 1.12
Cytomegaloviruses as common adventitious contaminants in primary African green monkey kidney cell cultures. J Natl Cancer Inst (1969) 1.09
Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res (1991) 1.09
Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine. J Pediatr (1992) 1.08
Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. Fundam Appl Toxicol (1993) 1.08
Screening for diabetic retinopathy. Med J Aust (1995) 1.07
A study of nurse children, 1550-1750. Local Popul Stud (1987) 1.07
How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England. Commun Dis Public Health (2004) 1.05
hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat (2003) 1.04
Inequalities of primary care microbiology testing between hospital catchment areas. J Clin Pathol (2003) 1.04
Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J Immunol (1988) 1.02
Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene (1997) 1.02
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days. Anticancer Drugs (1992) 1.01
The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res (2007) 1.01
Radioimmunoassay for mono-(2-ethylhexyl) phthalate in unextracted plasma. Clin Chem (1978) 1.01
Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line. J Natl Cancer Inst (2001) 0.98
Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Subst Use Misuse (1998) 0.98
Management of gynaecomastia: an update. Int J Clin Pract (2007) 0.97
The prevention of breast cancer: an overview. Curr Med Res Opin (2001) 0.97
Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens. Carcinogenesis (1995) 0.96
Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. Anticancer Res (2010) 0.96
The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol (2001) 0.94
Breast papillomas: current management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg Oncol (2006) 0.94
A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol (2006) 0.94
Development, validation and application of computer-linked knowledge questionnaires in diabetes education. Diabet Med (1988) 0.93
The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer. Am J Surg (1999) 0.93
Evolutionary conservation of the spliceosomal protein, U2B''. Nucleic Acids Res (1991) 0.93
Bitter-sweet symphony: defining the role of dendritic cell gp120 receptors in HIV infection. J Clin Virol (2001) 0.93
Mammographic breast density by area of residence: possible evidence of higher density in urban areas. Curr Med Res Opin (2008) 0.92
Pharmacokinetic study of fludarabine phosphate (NSC 312887). Cancer Chemother Pharmacol (1986) 0.92
Telomerase activity and lymphovascular invasion in breast cancer. Eur J Surg Oncol (2000) 0.92
A case of Fournier gangrene complicating idiopathic nephrotic syndrome of childhood. Pediatr Nephrol (1999) 0.91
Androgen priming and cytotoxic chemotherapy in advanced prostatic cancer. Cancer Chemother Pharmacol (1982) 0.91
Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. Cancer Res (2001) 0.91
Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party. Eur J Cancer (1992) 0.91
Photocoagulation and other therapy for histoplasmic choroiditis. Trans Am Acad Ophthalmol Otolaryngol (1968) 0.91
Evaluating needle exchange: do distributed needles come back? Am J Public Health (1991) 0.91
Carcinogenicity of TCDD in laboratory animals: implications for risk assessment. Toxicol Ind Health (1994) 0.90
Evidence for the management of mastalgia. Curr Med Res Opin (2004) 0.90
Direct cloning of human breast cancer in soft agar culture. Cancer (1982) 0.89
Isolation of a maize cDNA encoding a protein with extensive similarity to an inhibitor of protein kinase C and a cyanobacterial open reading frame. Biochim Biophys Acta (1994) 0.89
Laboratory studies on the immune effects of halogenated aromatics. Ann N Y Acad Sci (1979) 0.89
Control of aromatase activity in breast tumours: the role of the immune system. J Steroid Biochem Mol Biol (1997) 0.88
The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Eur J Surg Oncol (2002) 0.88
A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. J Pathol (1998) 0.88
Screening mammography in women aged 40-49: is it time to change? Int Semin Surg Oncol (2006) 0.88
Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer (1999) 0.87
Does post-mastectomy radiotherapy represent a contraindication to skin-sparing mastectomy and immediate reconstruction: an update. Surg Oncol (2012) 0.87
Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units. Anticancer Drugs (1997) 0.87
Sequence and expression of potato U2 snRNA genes. Nucleic Acids Res (1991) 0.87
Does mammary ductoscopy have a role in clinical practice? Int Semin Surg Oncol (2006) 0.87
Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung. Cancer Res (1981) 0.87
Carcinogen-specific mutational and epigenetic alterations in INK4A, INK4B and p53 tumour-suppressor genes drive induced senescence bypass in normal diploid mammalian cells. Oncogene (2012) 0.87
Cell-mediated mutagenesis in cultured Chinese hamster cells by carcinogenic polycyclic hydrocarbons: nature and extent of the associated hydrocarbon-DNA reaction. Mutat Res (1977) 0.86
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Evidence of a tumour suppressive function of E2F1 gene in human breast cancer. Anticancer Res (2008) 0.86
Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite. Cancer Res (1984) 0.86
Dobutamine vs furosemide in the treatment of cardiac failure due to right ventricular infarction. Chest (1980) 0.86
Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes. Int J Cancer (1980) 0.86
Oncological considerations of skin-sparing mastectomy. Int Semin Surg Oncol (2006) 0.86
Phytoestrogens and the risk of breast cancer: a review of the literature. Int J Fertil Womens Med (2006) 0.85
The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture. Mutat Res (1979) 0.85
Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. Anticancer Res (2006) 0.85